Volkswagen AG VLKPY Company Overview  Stock Message Board

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Volkswagen AG VLKPY Company Overview 

Stock Message Board http://investorshangout.com/search?q=VLKPY&am...mp;yt1=Go!

Volkswagen AG VLKPY Current Price and Quotes
45.29
Previous Close
45.91
Open
45.41

Daily Range
45.57 - 45.08
52wk Range
51.15 - 33.44

Volume
9,149
Dividend
0.6813

Average Vol (3m)
18,484
Yield
1.5

Volkswagen AG VLKPY

Company Verified Profile
Company Information
Berliner Ring 2
Wolfsburg 38440
Germany

Website: http://www.volkswagenag.com/ir
Phone: +49 (0) 5361-9-0
Email: investor.relations@volkswagen.de

Volkswagen AG VLKPY
The Volkswagen Group with its headquarters in Wolfsburg is one of the world’s leading automobile manufacturers and the largest carmaker in Europe. In 2011, the Group increased the number of vehicles delivered to customers to 8.265 million (2010: 7.203 million), corresponding to a 12.3 percent share of the world passenger car market.

In Western Europe over one in five new cars (23.0 percent) comes from the Volkswagen Group. Group sales revenue in 2011 totaled €159 billion (2010: €126....



Volkswagen AG VLKPY
Financial Reportings and Disclosures
Reporting Status International Reporting: Frankfurt Stock Exchange
Audited Financials Audited
Latest Report Jun 30, 2013 Interim Financial Report
CIK 0000839772
Fiscal Year End 12/31
OTC Marketplace OTCQX International Premier
Profile Data
SIC - Industry Classification 3711 - Motor vehicles and car bodies
Incorporated In: Germany
Year of Inc. 1961
Employees 513000 a/o Mar 31, 2012
Company Officers/Contacts
Martin Winterkorn CEO
Michael Macht COO
Hans Dieter Pötsch CFO
Michael Ganninger Counsel
Company Directors
Martin Winterkorn Chairman
Hussein Ali Al Abdalla
Jorgen Dorn
Annika Falkengren
Uwe Fritsch
Babette Froehlich
Berthold Huber
Khalifa Jassim Al Kuwari
Olaf Lies
Hartmut Meine
Peter Mosch
Bernd Osterloh
Ferdinand K. Piech
Hans-Michel Piech
Ursula Piech
Ferdinand Oliver Porsche
Wolfgang Porsche
Wolfgang Ritmeier
Juergen Stumpf
Bernd Wehlauer
Stephan Weil
Stephan Wolf
Thomas Zwiebler
Service Providers
DAD/PAL
J.P. Morgan
4 New York Plaza
14th Floor
New York, NY, 10004
United States

Auditor/Accountant
PricewaterhouseCoopers
Friedrich-Ebert-Anlage 35 - 37
60327 Frankfurt, Germany

Legal Counsel
Not Available
Investor Relations Firm
Not Available

Volkswagen AG VLKPY
VLKPY Security Details Other Company Securities
Share Structure
Market Value1 $66,823,089,286 a/o Aug 30, 2013
Shares Outstanding 295,089,818 a/o Sep 30, 2012
Float 143,800,000 a/o Dec 31, 2011
Authorized Shares Not Available
Par Value  No Par Value
Shareholders
Shareholders of Record Not Available
Corporate Actions
Ex. Date Record Date Pay Date
Dividend (0.68126) Apr 23, 2013 Apr 25, 2013 May 03, 2013
Dividend (0.68326) Apr 23, 2013 Apr 25, 2013 May 03, 2013
Dividend (0.59441) Apr 17, 2012 Apr 19, 2012 Apr 27, 2012
Non US Stock Exchange Listing
VOW - Frankfurt Stock Exchange - Qualified
Short Selling Data
Short Interest 3,858 (-16.26%)
Aug 15, 2013
Significant Failures to Deliver  No
Transfer Agent(s)
JPMorgan Depositary Receipts

Volkswagen AG VLKPY Recent News


Sept 1, 2013 NJ VW Dealers Learn about Announced Specials at World Volkswagen during Best.Thing.Ever. Event
Sept 1, 2013 North Star Hires Economic Development Branding Vice President
Aug 29, 2013 First Robot Collaborates Directly with Employees at Volkswagen Plant
Aug 29, 2013 Jiangsu Miracle Logistics Arm Wins CNY163mn Projects
Aug 29, 2013 The Zacks Analyst Blog Highlights: Magellan Midstream Partners, Ford Motor, Toyota Motor, General Motors and Volkswagen
Aug 29, 2013 Noyes Volkswagen Announces Sponsorship of Keene NH High School Youths to Soccer Camp in Wolfsburg, Germany
Aug 29, 2013 Volkswagen expansion in Chattanooga just a matter of time, Corker says
Aug 28, 2013 BRIEF: Cary High student struck by car outside school
Aug 28, 2013 Joyson Electronic H1 Net Up More than 80%
Aug 26, 2013 Supplier to Chattanooga's Volkswagen plant turns back UAW

12345678next >last >>

Volkswagen AG VLKPY Financials
Period Ending Dec 31, 2011
Total Revenue 206,845,000
Cost of Revenue 170,541,000
Gross Profit 36,303,000
Operating Expenses
Research and Development -
Sales, General and Admin. 21,673,000
Non-Recurring Items -
Other -
Operating Income 14,632,000
Income From Continuing Operations
Add'l Income/Expense Items 9,773,000
Earnings Before Interest and Tax 27,226,000
Interest Expense 2,657,000
Earnings Before Tax 24,569,000
Income Tax 4,058,000
Minority Interest 508,000
Equity Earnings Unconsolidated Subsidiary 2,822,000
Net Income Cont. Operations 22,826,000
Non Recurring Events
Discontinued Operations -
Extraordinary Items -
Effect of Accounting Changes -
Other Items -
Net Income 20,003,000
Preferred Stock and Other Adjustments -
Net Income Applicable to Common Shareholders 20,003,000

VLKPY Volkswagen AG Research DD Guide

VLKPY Volkswagen AG Stock Message Board http://investorshangout.com/search?q=VLKPY&am...mp;yt0=Go!
VLKPY Volkswagen AG Stock Quote http://www.otcmarkets.com/stock/VLKPY/quote
VLKPY Volkswagen AG Stock Chart http://www.otcmarkets.com/stock/VLKPY/chart
VLKPY Volkswagen AG Company Info http://www.otcmarkets.com/stock/VLKPY/company-info
VLKPY Volkswagen AG Recent News http://www.otcmarkets.com/stock/VLKPY/news
VLKPY Volkswagen AG Financials http://www.otcmarkets.com/stock/VLKPY/financials
VLKPY Volkswagen AG Filings and Disclosure http://www.otcmarkets.com/stock/VLKPY/filings
VLKPY Volkswagen AG Short Sales http://www.otcmarkets.com/stock/VLKPY/short-sales
VLKPY Volkswagen AG Insider Disclosure http://www.otcmarkets.com/stock/VLKPY/insider-transactions
VLKPY Volkswagen AG Research Reports http://www.otcmarkets.com/stock/VLKPY/research
VLKPY Volkswagen AG Summary http://finance.yahoo.com/q?s=VLKPY
VLKPY Volkswagen AG Historical Prices http://finance.yahoo.com/q/hp?s=VLKPY+Historical+Prices
VLKPY Volkswagen AG Interactive Chart http://finance.yahoo.com/echarts?s=VLKPY
VLKPY Volkswagen AG Basic Chart http://finance.yahoo.com/q/bc?s=VLKPY+Basic+Chart
VLKPY Volkswagen AG Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=VLKPY+Basic+Tech.+Analysis
VLKPY Volkswagen AG Headlines http://finance.yahoo.com/q/h?s=VLKPY+Headlines
VLKPY Volkswagen AG Press Releases http://finance.yahoo.com/q/p?s=VLKPY+Press+Releases
VLKPY Volkswagen AG Company Profile http://finance.yahoo.com/q/pr?s=VLKPY+Profile
VLKPY Volkswagen AG Key Statistics http://finance.yahoo.com/q/ks?s=VLKPY+Key+Statistics
VLKPY Volkswagen AG Industry http://finance.yahoo.com/q/in?s=VLKPY+Industry
VLKPY Volkswagen AG Major Holders http://finance.yahoo.com/q/mh?s=VLKPY+Major+Holders
VLKPY Volkswagen AG Insider Transactions http://finance.yahoo.com/q/it?s=VLKPY+Insider+Transactions
VLKPY Volkswagen AG Insider Roster http://finance.yahoo.com/q/ir?s=VLKPY+Insider+Roster
VLKPY Volkswagen AG Income Statement http://finance.yahoo.com/q/is?s=VLKPY
VLKPY Volkswagen AG Balance Sheet http://finance.yahoo.com/q/bs?s=VLKPY
VLKPY Volkswagen AG Cash Flow http://finance.yahoo.com/q/cf?s=VLKPY+Cash+Flow&annual
VLKPY Volkswagen AG Nasdaq http://www.nasdaq.com/symbol/VLKPY
VLKPY Volkswagen AG Market Watch http://www.marketwatch.com/investing/stock/VLKPY
VLKPY Volkswagen AG Bloomberg http://www.bloomberg.com/quote/VLKPY:US
VLKPY Volkswagen AG Morningstar http://quotes.morningstar.com/stock/s?t=VLKPY
VLKPY Volkswagen AG Bussinessweek http://investing.businessweek.com/research/st...cker=VLKPY
VLKPY Volkswagen AG Barchart http://www.barchart.com/quotes/stocks/VLKPY
VLKPY Volkswagen AG OTC Short Report http://otcshortreport.com/index.php?index=VLKPY
VLKPY Volkswagen AG Investopedia http://www.investopedia.com/markets/stocks/VLKPY/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 6

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 9

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 4

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 2

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 2

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 7

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 2

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 8

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 5

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Eye Class Action Lawsuit Against Smart Digital Group

Updated Category News Views 142

Class Action Lawsuit Overview Against Smart Digital Group Ltd. The Rosen Law Firm, recognized for advocating for investor rights globally, has initiated a class action lawsuit aimed at purchasers of securities from Smart Digital Group Ltd. (NASDAQ: SDM). This lawsuit encompasses transactions that occurred between May 5, 2025, and September 26, 2025. Investors who made...

Continue Reading
Join the Class Action Against Zeta Global Holdings Today

Updated Category News Views 108

Join the Class Action Against Zeta Global Holdings Levi & Korsinsky, LLP is reaching out to concerned investors in Zeta Global Holdings Corp. regarding a class action lawsuit that could affect many shareholders. This lawsuit aims to recover losses incurred by those negatively impacted by alleged securities fraud during a specific timeframe. Understanding the Class Action...

Continue Reading
EverBank Strengthens Equipment Finance with New Division

Updated Category News Views 209

EverBank Expands Its Equipment Finance Horizons EverBank is embarking on an exciting new journey by launching a Corporate Asset Finance division, enhancing its equipment finance capabilities significantly. This innovative step is set to offer structured equipment loans and leases to large and middle-market companies, ensuring that they receive the support they need to...

Continue Reading
USA Health and RLDatix Team Up for Enhanced Patient Safety

Updated Category News Views 122

USA Health and RLDatix Team Up for Enhanced Patient Safety In a significant development in the healthcare sector, USA Health has announced an expansion of its partnership with RLDatix, a trailblazer in healthcare operations software. This collaboration is designed to foster a safer healthcare environment, ensuring patients receive the highest standard of care. Empowering...

Continue Reading
Exciting Advancements in COVID-19 Vaccine Technology by Soligenix

Updated Category News Views 289

Soligenix’s CiVax™: A New Approach to COVID-19 Vaccination In a remarkable leap forward in the fight against COVID-19, Soligenix, Inc. (NASDAQ: SNGX), a biopharmaceutical company dedicated to rare disease treatments, has announced significant findings about its innovative vaccine candidate, CiVax™. This thermostabilized subunit vaccine has demonstrated promising...

Continue Reading